These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25167882)

  • 1. Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi.
    Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
    Ann Am Thorac Soc; 2014 Oct; 11(8):1298-306. PubMed ID: 25167882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD010004. PubMed ID: 32521055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010004. PubMed ID: 28000919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010004. PubMed ID: 23235684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2014 Dec; (12):CD010004. PubMed ID: 25470304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
    Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
    Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2016 Mar; 37(1):83-96. PubMed ID: 26857770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.
    Mussaffi H; Rivlin J; Shalit I; Ephros M; Blau H
    Eur Respir J; 2005 Feb; 25(2):324-8. PubMed ID: 15684298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontuberculous mycobacterial infections in cystic fibrosis.
    Martiniano SL; Nick JA
    Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
    Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
    Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nontuberculous mycobacteria in patients with cystic fibrosis.
    Leung JM; Olivier KN
    Semin Respir Crit Care Med; 2013 Feb; 34(1):124-34. PubMed ID: 23460012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis.
    Schwartz M; Fisher S; Story-Roller E; Lamichhane G; Parrish N
    Microb Drug Resist; 2018 Oct; 24(8):1191-1197. PubMed ID: 29368988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
    Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
    Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.
    Leung JM; Olivier KN
    Curr Opin Pulm Med; 2013 Nov; 19(6):662-9. PubMed ID: 24048085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
    Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
    Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Thorac Surg Clin; 2019 Feb; 29(1):95-108. PubMed ID: 30454926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing nontuberculous mycobacteria infection in cystic fibrosis.
    Bar-On O; Mussaffi H; Mei-Zahav M; Prais D; Steuer G; Stafler P; Hananya S; Blau H
    J Cyst Fibros; 2015 Jan; 14(1):53-62. PubMed ID: 24917112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Green H; Jones AM
    Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.
    Wijers CD; Chmiel JF; Gaston BM
    Chron Respir Dis; 2017 Nov; 14(4):392-406. PubMed ID: 29081265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens.
    Cogen JD; Onchiri F; Emerson J; Gibson RL; Hoffman LR; Nichols DP; Rosenfeld M
    Ann Am Thorac Soc; 2018 Jun; 15(6):702-709. PubMed ID: 29474110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.